Protea Biosciences, Inc. Concludes New Technology License Agreement

Published: Sep 08, 2010

NÎMES, France--(BUSINESS WIRE)--ProteaBio Europe SAS, a leading developer of new technology, announced today that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules.

Back to news